Journal article · 2025 · Open access

Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells

Yan-Ruide Li, Xinyuan Shen, Enbo Zhu, Zhe Li, Jie Huang, Thuc M. Le, Chau Tran, Caius G. Radu, Lili Yang

Proceedings of the National Academy of Sciences, 122(47), e2517786122 · Published 21 November 2025 · DOI 10.1073/pnas.2517786122

Open full textCite this paper

In brief

“Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells” is a 2025 journal article by Yan-Ruide Li and 8 co-authors, published in Proceedings of the National Academy of Sciences. OpenAlex counts 31 citations as of 17 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Proceedings of the National Academy of Sciences.

Citations
31
Most cited in
2026 (31)
Field-weighted impact
10.65
References
73
Authors
9

Abstract

Pancreatic cancer (PC) remains one of the leading causes of cancer-related mortality worldwide. The majority of patients are diagnosed at advanced stages, with over 50% presenting with metastatic disease at the time of diagnosis. Although chimeric antigen receptor (CAR)-T cell therapy has shown promise in targeting PC, its clinical efficacy remains limited due to several critical challenges. These include tumor antigen heterogeneity, antigen loss or escape mechanisms, functional exhaustion of CAR-T cells within the tumor microenvironment, as well as inherent limitations of autologous approaches such as high manufacturing costs, prolonged production timelines, and restricted scalability. To address these challenges, we developed allogeneic IL-15–enhanced, mesothelin-specific CAR-engineered invariant natural killer T ( Allo15 MCAR-NKT) cells through gene engineering of human hematopoietic stem and progenitor cells (HSPCs) using a clinically guided culture method. These Allo15 MCAR-NKT cells exhibited robust and multifaceted antitumor activity against PC, driven by both CAR and NK receptor–mediated cytotoxic mechanisms. In orthotopic and metastatic human PC xenograft models, Allo15 MCAR-NKT cells demonstrated superior tumor control, enhanced trafficking and infiltration into tumor sites, sustained effector and cytotoxic phenotypes, and reduced expression of exhaustion markers. Importantly, Allo15 MCAR-NKT cells demonstrated a favorable safety profile, characterized by the absence of graft-versus-host disease and minimal cytokine release syndrome. Collectively, these findings validate Allo15 MCAR-NKT cells as a promising next-generation, off-the-shelf immunotherapeutic approach for PC, with the potential to overcome critical challenges including tumor heterogeneity, immune evasion, and therapeutic resistance, especially in the context of metastatic disease.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Li, Y.-R., Shen, X., Zhu, E., Li, Z., Huang, J., Le, T. M., Tran, C., Radu, C. G., & Yang, L. (2025). Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells. Proceedings of the National Academy of Sciences, 122(47), e2517786122. https://doi.org/10.1073/pnas.2517786122

MLA 9

Li, Yan-Ruide, et al. “Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells.” Proceedings of the National Academy of Sciences, vol. 122, no. 47, 2025, p. e2517786122. https://doi.org/10.1073/pnas.2517786122.

Chicago

Li, Yan-Ruide, Xinyuan Shen, Enbo Zhu, Zhe Li, Jie Huang, Thuc M. Le, Chau Tran, Caius G. Radu, and Lili Yang. 2025. “Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells.” Proceedings of the National Academy of Sciences 122 (47): e2517786122. https://doi.org/10.1073/pnas.2517786122.

Harvard

Li, Y.-R. et al. (2025) ‘Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells’, Proceedings of the National Academy of Sciences, 122(47), p. e2517786122. doi:10.1073/pnas.2517786122.

IEEE

Y.-R. Li et al., “Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells,” Proceedings of the National Academy of Sciences, vol. 122, no. 47, p. e2517786122, 2025, doi: 10.1073/pnas.2517786122.

BibTeX

@article{li2025targeting,
  title     = {{Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells}},
  author    = {Li, Yan-Ruide and Shen, Xinyuan and Zhu, Enbo and Li, Zhe and Huang, Jie and Le, Thuc M. and Tran, Chau and Radu, Caius G. and Yang, Lili},
  journal   = {Proceedings of the National Academy of Sciences},
  year      = {2025},
  volume    = {122},
  number    = {47},
  pages     = {e2517786122},
  doi       = {10.1073/pnas.2517786122},
  url       = {https://doi.org/10.1073/pnas.2517786122}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • pancreatic cancer
  • mesothelin
  • hematopoietic stem and progenitor cells
  • IL-15
  • NK cell cytotoxicity
  • metastatic pancreatic cancer
  • tumor antigen heterogeneity
  • graft-versus-host disease

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Li, Y.-R., Shen, X., Zhu, E., Li, Z., Huang, J., Le, T. M., Tran, C., Radu, C. G., & Yang, L. (2025). Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells. Proceedings of the National Academy of Sciences, 122(47), e2517786122. https://doi.org/10.1073/pnas.2517786122

How many times has this paper been cited?

31 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Proceedings of the National Academy of Sciences: sign in and open the full text from this page.

Who wrote this paper?

Yan-Ruide Li, Xinyuan Shen, Enbo Zhu, Zhe Li, Jie Huang, Thuc M. Le, Chau Tran, Caius G. Radu, Lili Yang.

What is the DOI of this paper?

10.1073/pnas.2517786122, permanently at https://doi.org/10.1073/pnas.2517786122. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.